Earnings call transcript: EverGen Infrastructure Q2 2025 results disappoint

EverGen Infrastructure Corporation reported a significant earnings miss for Q2 2025, with an adjusted EPS of -$0.10 against a forecasted -$0.02 and revenue of $2.8 million falling short of the $4.41 million projection, leading to an 8.14% stock decline in after-hours trading. While revenue increased quarter-over-quarter and adjusted EBITDA improved, the company grapples with a substantial debt burden, cash burn, and an anticipated 33% sales decline for the current year. Despite these challenges, new management is focused on operational optimization, has secured regulatory approval for the key PCR RNG Expansion Project, and expects to finalize debt refinancing and a $2 million follow-on financing in September, aiming to stabilize operations and unlock long-term value from its core RNG assets.

Analysis

EverGen Infrastructure Corporation (EVGN) reported a significant miss for Q2 2025, with an adjusted EPS of -$0.10 against a -$0.02 forecast and revenue of $2.8 million falling 36.96% short of the $4.41 million projection. The market reacted negatively, sending the stock down 8.14% in after-hours trading to $0.395, near its 52-week low. Despite the miss, the results present a complex picture: revenue grew sequentially from $1.9 million in Q1 2025 and adjusted EBITDA improved to -$300,000 from -$500,000 in the prior quarter, supported by record production from its core RNG assets. However, revenue declined year-over-year, and analysts project a 33% sales decline for the full year, reflecting challenges including lower tipping revenues and high cash burn. The narrative is now dominated by a turnaround effort led by a new management team focused on operational optimization. Key potential catalysts are on the horizon, including the expected closing of a crucial debt refinancing and a $2 million follow-on financing in September. Furthermore, the company recently achieved a major de-risking milestone by securing regulatory approval for its PCR RNG Expansion Project after a two-year delay, positioning it to be 'shovel-ready' within 6-12 months. The current strategy involves accepting short-term revenue impacts, such as intentionally reducing composting volumes, to prepare assets for long-term value creation through RNG expansion.

Key Decisions for Investors

• Investors should view EVGN as a high-risk, high-reward turnaround play, weighing the significant execution risk of the new management team against the potential for valuation upside if asset optimization and project development succeed.
• Closely monitor the announced debt refinancing and $2 million follow-on financing, expected in September, as their successful completion is critical to alleviating the company's capital constraints and validating management credibility.
• Future earnings reports should be scrutinized for evidence of stabilized RNG production and sequential improvements in adjusted EBITDA, which would signal that the new operational strategy is gaining traction.
• Pay close attention to any management updates on the 'shovel-ready' timeline for the now-approved PCR RNG Expansion Project, as progress on this front represents the most significant near-term value driver for the company.